title: Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism.
abstract: In acute myeloid leukemia (AML), the chances of achieving disease-free survival are low. Studies have demonstrated a supportive role of endothelial cells (ECs) in normal hematopoiesis. Here we show that similar intercellular relationships exist in leukemia. We demonstrate that leukemia cells themselves initiate these interactions by directly modulating the behavior of resting ECs through the induction of EC activation. In this inflammatory state, activated ECs induce the adhesion of a sub-set of leukemia cells through the cell adhesion molecule E-selectin. These adherent leukemia cells are sequestered in a quiescent state and are unaffected by chemotherapy. The ability of adherent cells to later detach and again become proliferative following exposure to chemotherapy suggests a role of this process in relapse. Interestingly, differing leukemia subtypes modulate this process to varying degrees, which may explain the varied response of AML patients to chemotherapy and relapse rates. Finally, because leukemia cells themselves induce EC activation, we postulate a positive-feedback loop in leukemia that exists to support the growth and relapse of the disease. Together, the data defines a new mechanism describing how ECs and leukemia cells interact during leukemogenesis, which could be used to develop novel treatments for those with AML.
authors.affiliation: Department of Biological Sciences, Oakland University, Rochester, Michigan, USA.
authors.forename: Bahareh
authors.initials: B
authors.lastname: Pezeshkian
authors.forename: Christopher
authors.initials: C
authors.lastname: Donnelly
authors.forename: Kelley
authors.initials: K
authors.lastname: Tamburo
authors.forename: Timothy
authors.initials: T
authors.lastname: Geddes
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Madlambayan
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D002448:Cell Adhesion; D002450:Cell Communication; D045744:Cell Line, Tumor; D018920:Coculture Techniques; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D019040:E-Selectin / Q000378:metabolism; D025461:Feedback, Physiological / Q000187:drug effects; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism* / Q000473:pathology*; D012008:Recurrence; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D019040:E-Selectin; C546936:SELE protein, human
references.citation: Blood. 2010 Sep 2;116(9):1539-47
references.pmid: 20472832
references.citation: Blood. 2000 Jan 1;95(1):309-13
references.pmid: 10607717
references.citation: Nature. 2005 Jun 16;435(7044):969-73
references.pmid: 15959517
references.citation: Curr Vasc Pharmacol. 2005 Jan;3(1):11-39
references.pmid: 15638780
references.citation: EMBO J. 1999 Mar 15;18(6):1516-25
references.pmid: 10075923
references.citation: Nat Med. 2004 Jan;10(1):64-71
references.pmid: 14702636
references.citation: Blood. 2001 Apr 1;97(7):2121-9
references.pmid: 11264180
references.citation: Leukemia. 2007 Jan;21(1):136-42
references.pmid: 17039228
references.citation: Lab Invest. 1967 Sep;17(3):334-49
references.pmid: 6051014
references.citation: Leukemia. 2002 Jan;16(1):112-9
references.pmid: 11840270
references.citation: Blood. 2007 Mar 15;109(6):2365-72
references.pmid: 17095624
references.citation: Blood. 2005 Jan 15;105(2):576-83
references.pmid: 15345596
references.citation: J Immunol. 2008 Jul 15;181(2):1480-90
references.pmid: 18606703
references.citation: Blood. 2001 Jun 1;97(11):3658-61
references.pmid: 11369666
references.citation: Nat Med. 2006 Oct;12(10):1167-74
references.pmid: 16998484
references.citation: Blood. 2008 Feb 15;111(4):1951-61
references.pmid: 18024794
references.citation: Toxicol Pathol. 2010 Oct;38(6):856-71
references.pmid: 20716788
references.citation: J Clin Invest. 2006 May;116(5):1195-201
references.pmid: 16670760
references.citation: Circ Res. 2006 Feb 3;98(2):159-62
references.pmid: 16456105
references.citation: Leuk Lymphoma. 1993 Dec;12(1-2):103-8
references.pmid: 8161925
references.citation: Leukemia. 1995 May;9(5):869-74
references.pmid: 7539515
references.citation: Ann Biomed Eng. 2012 Apr;40(4):849-59
references.pmid: 22271244
references.citation: Nat Med. 2003 Sep;9(9):1158-65
references.pmid: 12897778
references.citation: Cell. 2005 Jul 1;121(7):1109-21
references.pmid: 15989959
references.citation: Arthritis Res Ther. 2012 Apr 25;14(2):R88
references.pmid: 22534470
references.citation: Eur J Haematol. 2007 May;78(5):365-73
references.pmid: 17391308
references.citation: Br J Haematol. 1993 Oct;85(2):285-91
references.pmid: 7506565
references.citation: Biol Blood Marrow Transplant. 2006 May;12(5):530-40
references.pmid: 16635788
references.citation: J Leukoc Biol. 2007 Jun;81(6):1599-608
references.pmid: 17347302
references.citation: Blood. 2004 Nov 1;104(9):2752-60
references.pmid: 15226175
references.citation: Int J Cancer. 2006 Nov 15;119(10):2313-21
references.pmid: 16921487
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10623-8
references.pmid: 12963823
references.citation: Haematologica. 2006 Sep;91(9):1203-11
references.pmid: 16956819
references.citation: Br J Haematol. 2009 Jan;144(1):53-68
references.pmid: 19016730
references.citation: Blood. 2009 Jun 11;113(24):6246-57
references.pmid: 19211506
references.citation: Carcinogenesis. 2009 Jul;30(7):1073-81
references.pmid: 19468060
references.citation: Leukemia. 2009 Dec;23(12):2248-58
references.pmid: 19741727
references.citation: Blood. 1994 Mar 15;83(6):1619-25
references.pmid: 8123853
references.citation: Blood. 2007 Mar 15;109(6):2314-21
references.pmid: 17158236
references.citation: Exp Hematol. 2004 Mar;32(3):308-17
references.pmid: 15003317
references.citation: Science. 2008 Dec 19;322(5909):1861-5
references.pmid: 19095944
references.citation: Leukemia. 2012 Jan;26(1):54-62
references.pmid: 21886170
references.citation: Exp Hematol. 2004 Dec;32(12):1226-37
references.pmid: 15588947
references.citation: Nat Biotechnol. 2010 Mar;28(3):275-80
references.pmid: 20160717
references.citation: J Natl Cancer Inst. 2011 Jun 8;103(11):893-905
references.pmid: 21487100
references.citation: Ann Oncol. 2004 Jan;15(1):139-45
references.pmid: 14679134
references.citation: Nat Biotechnol. 2007 Nov;25(11):1315-21
references.pmid: 17952057
references.citation: J Immunol. 1996 Nov 1;157(9):3995-4004
references.pmid: 8892633
references.citation: Blood. 2007 Nov 1;110(9):3334-44
references.pmid: 17638851
references.citation: Clin Exp Metastasis. 2008;25(4):335-44
references.pmid: 17891461
references.citation: Blood. 1997 Mar 15;89(6):1870-5
references.pmid: 9058706
references.citation: Blood. 2005 Aug 15;106(4):1154-63
references.pmid: 15870183
references.citation: Leukemia. 2010 Jul;24(7):1247-8
references.pmid: 20628414
references.citation: Blood. 2009 Feb 26;113(9):2104-7
references.pmid: 19141867